Northwest Biotherapeutics, Inc.
(Other OTC/NBB : NWBO)

( )
NWBO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corp.
0.10%108.241.3%$1555.46m
BIIBBiogen, Inc.
-0.01%285.401.4%$826.42m
AMGNAmgen, Inc.
0.45%225.511.3%$560.39m
GILDGilead Sciences, Inc.
-0.19%64.881.0%$407.05m
VRTXVertex Pharmaceuticals, Inc.
0.03%215.071.9%$345.44m
ILMNIllumina, Inc.
1.25%314.913.5%$336.38m
REGNRegeneron Pharmaceuticals, Inc.
-0.06%344.242.6%$279.87m
EXASEXACT Sciences Corp.
0.16%83.9324.0%$220.79m
ALXNAlexion Pharmaceuticals, Inc.
-1.92%108.532.0%$184.76m
BMRNBioMarin Pharmaceutical, Inc.
-0.39%77.434.3%$134.14m
SRPTSarepta Therapeutics, Inc.
4.35%102.3014.6%$126.57m
SGENSeattle Genetics, Inc.
2.51%120.846.1%$125.11m
AAgilent Technologies, Inc.
-1.00%78.501.6%$103.06m
BGNEBeiGene Ltd.
-0.29%203.312.1%$94.15m
NBIXNeurocrine Biosciences, Inc.
0.31%113.085.0%$92.24m

Company Profile

Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.